Lilly to Build $3B Manufacturing Facility in Netherlands
Eli Lilly and Company is investing $3 billion to build a new manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park....
FDA Unveils Initiative for Faster Biosimilar Development
The U.S. Food and Drug Administration (FDA) has unveiled a major initiative aimed at cutting both the time and cost required to develop biosimilar...
Novartis to Acquire Avidity Biosciences in $12 Billion Deal
Swiss pharmaceutical company Novartis announced that it has reached an agreement to acquire U.S.-based biotechnology firm Avidity Biosciences in a cash deal valued at...
Pharma Manufacturing Hubs in the Middle East
Middle East Pharma Hubs: Building Global-Standard Manufacturing Ecosystems
The pharmaceutical landscape across the Middle East is undergoing a remarkable transformation. What was once a region...
Carbon-Neutral Bioprocessing in Pharmaceuticals
Green Bioprocessing: Towards a Carbon-Neutral Pharmaceutical Industry
The pharmaceutical industry stands at a critical crossroads where innovation meets environmental responsibility. As global awareness of climate...
Precision Fermentation and the Future of Biomanufacturing
Precision Fermentation: Unlocking the Future of Biomanufacturing
The convergence of synthetic biology, advanced fermentation techniques, and computational design has given rise to precision fermentation, a...
Strengthening Biotech Supply Chains in the Middle East
From Lab to Market: Building Regional Biotech Supply Chains
The transformation of a promising therapeutic discovery into a medicine available to patients requires navigating one...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...